Home > About Us

About Us

Bispecific Antibody Research & Development

About Creative BiolabsAdvancing Bispecific Antibody Research Through Integrated Design, Engineering, and Evaluation

From target-pair strategy and molecular architecture to production, characterization, and preclinical research, we help scientific teams build evidence around the decisions that shape a bispecific antibody program.

Integrated R&D for bispecific and multispecific antibody programs

Creative Biolabs provides integrated research and development services for bispecific and multispecific antibody programs. We work with academic, biotechnology, and pharmaceutical teams to address the scientific and technical challenges associated with target selection, molecular format, chain pairing, expression, purification, developability, functional validation, and early preclinical decision-making.

Our focus is not on delivering isolated assays or standard constructs. We build application-driven, mechanism-aware workflows that connect molecular design with manufacturability and biological function, helping teams move from an early concept to a well-characterized research candidate with clearer evidence for the next decision.

Bispecific antibody research and molecular design visualization
One connected workflow Mechanism · Molecule · Evidence

More than affinity. More than a single format.

The performance of a bispecific antibody depends on how design variables work together. We evaluate these variables in the context of the complete molecule and its intended research use.

Target PairingConnect target biology to the intended mechanism and experimental question.
Epitope GeometryConsider binding orientation, spatial arrangement, and productive target engagement.
Valency & ArchitectureBalance avidity, selectivity, molecular size, and functional requirements.
Domain & Linker DesignOptimize arrangement, flexibility, chain pairing, and structural behavior.
Fc BehaviorAlign Fc properties with the desired biological function and study design.
DevelopabilityExamine expression, purification, stability, aggregation, and downstream risk.

Connected support across the R&D continuum

Each stage is planned around the same program question, so molecular design, material generation, analytical data, and biological evidence remain connected.

01

Discovery & Mechanism-Guided Design

Define the target pair, intended biology, binding geometry, valency, and architecture before construct generation begins.

Explore design services
02

Format Engineering & Molecular Generation

Develop IgG-like, fragment-based, fusion, conjugate, and multispecific formats with function and downstream studies in view.

Explore engineering
03

Expression, Production & Purification

Generate fit-for-purpose material through recombinant, cell-free, high-throughput, conjugation, or hybrid-hybridoma routes.

Explore purification
04

Analytical & Functional Characterization

Evaluate identity, purity, structure, stability, binding, and mechanism-aligned functions, with in vitro and in vivo strategies selected for the program question.

Explore analysis
05

Developability & Early Preclinical Research

Integrate developability, sequencing, PK/PD, and preclinical studies to compare candidates and reveal risks beyond potency.

Explore platforms

Multiple development routes, selected around the biology

Our portfolio supports different mechanisms, molecular architectures, emerging modalities, and acceleration strategies rather than forcing every program into one scaffold or workflow.

Bispecific antibody engineering formats and platform development
The molecule follows the biology Architecture and evaluation are aligned with mechanism, study context, and downstream decisions.
01

Mechanism-Driven Programs

T-cell, NK-cell, and macrophage engagers; signaling interference; forced protein association; pretargeting; and payload delivery.

02

Format-Flexible Engineering

IgG-like BsAbs, pairing strategies, tandem scFv, diabody, single-domain antibody, minibody, Fab fragments, fusion proteins, Fc fusions, and conjugates.

03

Emerging Modalities

Biparatopic and trispecific antibodies, bispecific ADCs, bispecific aptamers, aptamer-drug conjugates, antibody mimetics, and BBB-penetrating concepts.

04

Acceleration Platforms

High-throughput parent-antibody screening and expression, AI-assisted optimization, cell-free expression, sequencing, and developability assessment.

Project design tailored to the scientific objective

Bispecific and multispecific formats can redirect immune cells, modulate more than one disease pathway, increase target selectivity, transport payloads, or enable new binding geometries. We tailor project design to the biology and research objective rather than to a single therapeutic area.

Our capabilities can support diverse research applications wherever coordinated target engagement may provide a useful experimental strategy.

Coordinated Target Engagement
Oncology
Immunology
Hematology
Neurology & CNS Delivery
Ophthalmology
Pulmonary Research
Imaging & Diagnostics

A workflow built around the next decision

Projects can begin with a target pair, a defined construct, existing material, or a specific technical bottleneck. The workflow is shaped around what the program needs to learn next.

Define the Question

Clarify the target pair, mechanism, study context, available materials, and the decision the project must support.

Build the Strategy

Recommend the format, engineering route, expression system, purification approach, and analytical package.

Generate & Test

Produce constructs and evaluate them using fit-for-purpose biochemical, biophysical, binding, and functional methods.

Interpret & Iterate

Review results together to compare candidates, identify risks, and select the next design or study decision.

Evidence stays connected from design through evaluation

Our role is to make the scientific and technical trade-offs visible, so the next program decision is supported by a coherent body of evidence.

Connected Decision-MakingDesign, production, analytics, and function are planned as one evidence-generating workflow.
Format BreadthMultiple antibody architectures and generation routes allow the molecule to follow the biology.
Problem-Focused FlexibilityStart with a defined construct, an unresolved target pair, or a specific technical bottleneck.
Mechanism-Aligned EvaluationSelect study packages around the intended function and the decision required at each stage.
Collaborative CommunicationKeep scope, milestones, outputs, and technical observations visible throughout the project.

Online Inquiry